WELLS FARGO & COMPANY/MN - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$537,320
+441.3%
112,410
+381.3%
0.00%
Q2 2023$99,263
-63.0%
23,356
-53.8%
0.00%
Q1 2023$268,505
+2415.0%
50,566
+2874.5%
0.00%
Q4 2022$10,676
-63.2%
1,700
-38.4%
0.00%
Q3 2022$29,000
+123.1%
2,761
+22.0%
0.00%
Q2 2022$13,000
-90.3%
2,263
-84.5%
0.00%
Q1 2022$134,000
-66.0%
14,612
-43.9%
0.00%
Q4 2021$394,000
+1171.0%
26,060
+1901.5%
0.00%
Q3 2021$31,0001,3020.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders